| Date | Title | Description |
| 06.01.2014 | C-Pulse device designed to help patients with advanced heart failure | Early results shows that the device has good results in patients with class three and four heart failure, an advanced disease state that can severely limit the ability of patients to do normal, day-to-day activities.
In a handful of cases, ... |
| 24.05.2013 | Sunshine Heart seeks $25.5M in equity funding round | Wall Street Beat | Eden Prairie, Minn., and Sydney-based medical device company Sunshine Heart (ASX:SHC) is looking to raise funds in a $25.5 million equity funding round, according to document filed with the SEC earlier this month.
Sunshine Heart reported th... |
| 19.03.2012 | HeartWare lands FDA OK for extended trial ahead of PMA review | Regulatory Roundup | HeartWare lands approval for a 4th round of pivotal trials for its HVAD ventricular assist device
HeartWare International (NSDQ:HTWR) won the FDA’s okay to add 54 patients to a pivotal U.S. trial of its ventricular assist system as a bridge... |
| 23.09.2011 | Sunshine Heart’s balloon device shows promise in heart failure study | The results of the trial, if confirmed via further study, help validate the company’s technology and push it farther down the path to regulatory clearance or approval.
Sunshine Heart plans to file a Premarket Approval Application (PMA) with... |
| 25.07.2011 | Cardiac medical device firm Sunshine Heart raises $5 million | Sunshine Heart is listed on the Australian stock exchange and investors in this round are buying shares at Australian 4 cents (4 cents) a share.
The company is developing the C-Pulse(R) Heart Assist System, an implantable, nonblood contacti... |
| 25.07.2011 | Cardiac medical device firm Sunshine Heart raises $4.6 million | Funding Roundup | Cardiac medical device firm Sunshine Heart (ASX:SHC) raised $4.6 million by selling 115 million shares in a private placement with institutional investors in the U.S. and Canada at 4 cents per share.
The Eden Prairie, Minnesota-based compan... |
| 07.12.2010 | Sunshine Heart sets on $9.4 million | Sunshine Heart Inc. (ASX:SHC) raised $9.4 million, including $3.5 million from the sale of equity and options in the U.S., according to documents filed with the federal Securities & Exchange Commission.
The company, based in Australia a... |
| 03.12.2010 | Aussie/Minnesota medical device firm Sunshine Heart raises $9.4M | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| 20.09.2010 | Sunshine Hearts shines on $3.5 million | Institutional investors in the U.S. have committed to buy a $3.5 million stake in Sunshine Heart Inc. (ASX:SHC) shares in a private placement — provided the company’s Australian shareholders agree.
The medical device company — which started... |
| 17.09.2010 | Sunshine Heart aims $3.5M+ heart failure device approvals | The company whose shares trade for a couple Australian cents on the Australian Securities Exchange received Food and Drug Administration approval to begin a 20-patient clinical feasibility trial in 2008 (pdf).
The first two moderate heart f... |
| - | Aussie/Minnesota medical device firm Sunshine Heart raises $9.4M | Sunshine Heart Inc. has raised $9.4 million, including $3.5 million from the sale of equity and options in the United States, according to documents filed with the Securities and Exchange Commission.
The company, based in Australia and Eden... |
| - | Sunshine Heart’s balloon device shows promise in heart failure study | A cardiac medical device from Sunshine Heart that uses a balloon to assist the heart in pumping blood has shown promise in a clinical trial led by Ohio State University Medical Center (OSUMC).
Patients enrolled in a multicenter North Americ... |
| - | Sunshine Heart aims $3.5M+ heart failure device approvals | Institutional investors in the United States have committed to buy $3.5 million-worth of Sunshine Heart Inc. (ASX: SHC) shares in a private placement — that is, if the company’s Australian shareholders agree.
The medical device company that... |
| - | C-Pulse device designed to help patients with advanced heart failure | A company that has created a unique new therapy for patients with advanced heart failure is hoping to spread the word about its product in 2014, after a year of clinical trials in both Europe and the United States.
Sunshine Heart, based in ... |
| - | Cardiac medical device firm Sunshine Heart raises $5 million | CORRECTED
Eden Prairie, Minnesota-based cardiac medical device firm Sunshine Heart has raised Australian $4.6 million ($5.03 million) by selling 115 million shares in a private placement with institutional investors in the U.S. and Canada, ... |
